Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.6K Buy
1,411
+600
+74% +$11.5K ﹤0.01% 4528
2025
Q4
$18K Buy
811
+100
+14% +$2.39K ﹤0.01% 4882
2025
Q3
$19.4K Sell
711
-3,554
-83% -$107K ﹤0.01% 4936
2025
Q2
$123K Buy
4,265
+1,115
+35% +$31.6K ﹤0.01% 4516
2025
Q1
$90.4K Sell
3,150
-29
-0.9% -$1.1K ﹤0.01% 4444
2024
Q4
$142K Sell
3,179
-27
-0.8% -$1.27K ﹤0.01% 4475
2024
Q3
$142K Buy
+3,206
New +$131K ﹤0.01% 4470
2024
Q2
Sell
-3,569
Closed -$175K 4959
2024
Q1
$175K Buy
3,569
+937
+36% +$45K ﹤0.01% 4194
2023
Q4
$127K Sell
2,632
-397
-13% -$17.7K ﹤0.01% 4575
2023
Q3
$123K Sell
3,029
-251
-8% -$9.94K ﹤0.01% 3518
2023
Q2
$129K Buy
3,280
+3,275
+65,500% +$119K ﹤0.01% 3460
2023
Q1
$204 Hold
5
﹤0.01% 4977
2022
Q4
$166 Sell
5
-3
-38% -$90 ﹤0.01% 5191
2022
Q3
$0 Buy
8
+5
+167% +$152 ﹤0.01% 4856
2022
Q2
$0 Sell
3
-106
-97% -$4.02K ﹤0.01% 5077
2022
Q1
$5K Buy
+109
New +$5.6K ﹤0.01% 4694

Other funds holding DCBO

Barclays's DCBO Position: Q1 2026 in Review

Barclays increased its Docebo (DCBO) stake by 74% in Q1 2026, buying an estimated $11.5K and bringing the position to 1,411 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4528.

Barclays first reported a position in DCBO in Q1 2022 and has held it in 16 quarters since. The position peaked at $175K in Q1 2024. 67 funds tracked by Wall St. Rank hold DCBO as of Q1 2026.

  • Barclays held 1,411 shares of Docebo worth $24.6K as of Q1 2026.
  • Barclays bought 600 Docebo shares in Q1 2026, an estimated $11.5K.
  • Docebo made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4528 holding.
  • Barclays first reported a position in Docebo in Q1 2022 and has held it in 16 quarters since.
  • Barclays's Docebo position peaked at $175K in Q1 2024.
  • 67 funds tracked by Wall St. Rank held Docebo as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.